0000926617-20-000012.txt : 20200331 0000926617-20-000012.hdr.sgml : 20200331 20200331145459 ACCESSION NUMBER: 0000926617-20-000012 CONFORMED SUBMISSION TYPE: NT 10-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191231 FILED AS OF DATE: 20200331 DATE AS OF CHANGE: 20200331 EFFECTIVENESS DATE: 20200331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VERMILLION, INC. CENTRAL INDEX KEY: 0000926617 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 330595156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34810 FILM NUMBER: 20761300 BUSINESS ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 BUSINESS PHONE: 512-519-0400 MAIL ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 FORMER COMPANY: FORMER CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC DATE OF NAME CHANGE: 20000316 FORMER COMPANY: FORMER CONFORMED NAME: ABIOTIC SYSTEMS DATE OF NAME CHANGE: 19950407 NT 10-K 1 vrml-20200331form_nt10k.htm NT 10-K Form 12b-25 10-K extension 033120



 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 12b-25

 

 

NOTIFICATION OF LATE FILING

SEC File Number_001-34810__________

CUSIP Number_92407M206__________

(Check one):    

 

  Form 10-K       Form 20-F       Form 11-K       Form 10-Q

  Form 10-D       Form N-CEN    Form N-CSR    



For Period Ended:   December 31, 2019     

  Transition Report on Form 10-K

 

 

  Transition Report on Form 20-F

 

 

  Transition Report on Form 11-K

 

 

  Transition Report on Form 10-Q

 

 

 For the Transition Period Ended:

 

________________  


Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

 

PART I — REGISTRANT INFORMATION

Vermillion, Inc.

(Full Name of Registrant)





(Former Name if Applicable)

12117 Bee Caves Road, Building Three, Suite 100

(Address of Principal Executive Office (Street and Number))

Austin, TX 78738

(City, State and Zip)

 

 

PART II — RULES 12b-25(b) AND (c)


 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 

 

 

 

 

 

 

   

 

(a)

 

The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

 

 

 

 

(b)

 

The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

 

 

 

 

 

(c)

 

The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

 


 



 

PART III — NARRATIVE

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

Vermillion, Inc. (the “Company”) was unable to file with the Securities and Exchange Commission the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 (the “Form 10-K”) by the prescribed due date without unreasonable effort and expense. The Company has negotiated an amendment (the “Amendment”) to the Assistance Agreement, effective March 22, 2016 (as amended to date, the “Loan Agreement”), between the Company and the State of Connecticut Department of Economic and Community Development to restore the Company’s compliance with the terms of the Loan Agreement.  However, due to the current COVID-19 pandemic-related work restrictions and closures, including pursuant to the “Stay Safe, Stay Home” restrictions on all workplaces for non-essential business in Connecticut, the Company experienced delays and logistical issues finalizing the Amendment, the result of which is expected to impact the Company’s Form 10-K disclosure. The Company currently expects to finalize the Amendment and file the Form 10-K on or before April 14, 2020.

 

PART IV — OTHER INFORMATION

(1)   Name and telephone number of person to contact in regard to this notification

 

 

 

 

 

 

 

 

 

 

Robert Beechey, Chief Financial Officer     

 

 

    

(585)

  

 

  

491-4199

(Name)

 

 

    

(Area Code)

  

 

  

(Telephone Number)

 

(2

Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).      ☒  Yes      No

 

(3

Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?      ☐  Yes      No

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

Vermillion, Inc.

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

 

 

 

 

 

Date 

 

March 31, 2020

 

 

 

By 

 

 

 

/s/ Robert Beechey

 

 

 

 

 

 

 

 

 

 

Robert Beechey

 

 

 

 

 

 

 

 

 

 

Chief Financial Officer

INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.

ATTENTION

Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).